IP Library Granted Patent US 11,162,132
Granted Patent B2
US 11,162,132 · App. 17/237,670 · Granted Nov 2, 2021

Spatially distinguished, multiplex nucleic acid analysis of biological specimens

Inventors: Jonas Frisen (Stockholm, SE); Patrik Stahl (Stockholm, SE); Joakim Lundeberg (Lidingö, SE); Gordon M. Cann (San Diego, CA); Leila Bazargan (San Diego, CA); Alex Aravanis (San Diego, CA)
Assignees: Spatial Transcriptomics AB; Illumina, Inc.
C12Q1/6834C12Q1/6841C12Q1/6874C12Q1/6876
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,162,132
App. No.
17/237,670
Granted
Nov 2, 2021
Kind
B2
Abstract

A method for spatially tagging nucleic acids of a biological specimen, including steps of (a) providing a solid support comprising different nucleic acid probes that are randomly located on the solid support, wherein the different nucleic acid probes each includes a barcode sequence that differs from the barcode sequence of other randomly located probes on the solid support; (b) performing a nucleic acid detection reaction on the solid support to locate the barcode sequences on the solid support; (c) contacting a biological specimen with the solid support that has the randomly located probes; (d) hybridizing the randomly located probes to target nucleic acids from portions of the biological specimen; and (e) modifying the randomly located probes that are hybridized to the target nucleic acids, thereby producing modified probes that include the barcode sequences and a target specific modification, thereby spatially tagging the nucleic acids of the biological specimen.

Claims (31)

1. A method for determining the spatial location of a target nucleic acid in a biological specimen, comprising:

(a) providing a solid support comprising a population of nucleic acids randomly located across a population of features of said solid support, wherein the nucleic acids comprise a spatial tag sequence and a primer binding sequence, and wherein the spatial tag sequence differs from spatial tag sequences of other nucleic acids in the population;

(b) performing a sequencing reaction to determine the spatial tag sequences, or complements thereof, of the nucleic acids located across the population of features on the solid support, thereby determining the positions of the spatial tag sequences on the solid support;

(c) contacting a biological specimen with the solid support;

(d) hybridizing a target nucleic acid from the biological specimen to a capture sequence on a randomly located nucleic acid that is proximal to the target nucleic acid;

(e) producing a nucleic acid that comprises a sequence complementary to the target nucleic acid hybridized to the capture sequence, or a portion thereof, a spatial tag sequence or a complement thereof, and a primer binding sequence or a complement thereof; and

(f) determining the sequence of the spatial tag sequence or complement thereof, and all or a portion of the target nucleic acid sequence, or a complement thereof, thereby determining the spatial location of the target nucleic acid in the biological specimen.

2. The method of claim 1 , wherein the population of features is selected from the group consisting of pits, wells, channels, ridges, raised regions, pegs, posts and beads.

3. The method of claim 2 , wherein the population of features on the solid support have an average pitch of less than 10 82 m.

4. The method of claim 2 , wherein the population of features on the solid support have an average pitch of less than 5 μm.

5. The method of claim 2 , wherein the population of features on the solid support have an average pitch of less than 1 μm.

6. The method of claim 1 , wherein the solid support comprises fiducial markers.

7. The method of claim 1 , wherein the solid support comprises a gel coating.

8. The method of claim 1 , wherein the solid support is located in or on a flow cell.

9. The method of claim 1 , wherein capture sequences on the nucleic acids comprise different target capture sequences that hybridize to different target nucleic acids from the biological specimen.

10. The method of claim 1 , wherein capture sequences on the nucleic acids comprise a common target capture sequence, and the common target capture sequence comprises a polyT or polyA sequence.

11. The method of claim 1 , wherein the method further comprises a step of acquiring an image of the biological specimen in contact with the solid support, and a step of correlating the determined spatial tag sequences, or complements thereof, at the randomly located positions on the solid support with locations in the image of the biological specimen.

12. The method of claim 1 , wherein producing the nucleic acid in step (e) comprises extending the capture sequence using the captured target nucleic acid as a template.

13. The method of claim 12 , further comprises amplifying the nucleic acid with a primer complementary to the primer binding sequence, thereby generating an amplification product comprising all or a portion of the target nucleic acid, or a complement thereof, and the spatial tag sequence, or a complement thereof.

14. The method of claim 13 , wherein amplifying is selected from the group consisting of polymerase chain reaction, rolling circle amplification, multiple strand displacement amplification, and random prime amplification.

15. The method of claim 14 , wherein amplifying is polymerase chain reaction.

16. The method of claim 14 , wherein amplifying is rolling circle amplification.

17. The method of claim 1 , wherein determining the sequence in step (f) comprises sequencing.

18. The method of claim 17 , wherein sequencing comprises sequencing-by-synthesis, sequencing-by-hybridization or sequencing-by-ligation.

19. The method of claim 1 , wherein the biological specimen that is contacted with the solid support is a mixture of cells, and step (c) further comprises contacting the cells to the solid support and/or lysing the cells to release the target nucleic acid from the cells.

20. The method of claim 1 , wherein the biological specimen that is contacted with the solid support is a tissue, and step (c) further comprises contacting the tissue to the solid support and/or permeabilizing the tissue to release the target nucleic acid from the tissue.

21. The method of claim 1 , wherein the target nucleic acid is RNA.

22. The method of claim 21 , wherein the RNA is mRNA.

23. The method of claim 1 , wherein the target nucleic acid is DNA.

24. The method of claim 23 , wherein the DNA is genomic DNA.

25. The method of claim 1 , wherein the method further comprises staining the biological specimen.

Assignments (3)
CHANGE OF NAME Recorded Jul 25, 2023
From: SPATIAL TRANSCRIPTOMICS AB
To: 10X GENOMICS SWEDEN AB
Reel/Frame 064373/0360 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2021
From: FRISEN, JONAS; STAHL, PATRIK; LUNDEBERG, JOAKIM
To: SPATIAL TRANSCRIPTOMICS AB
Reel/Frame 056069/0264 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2021
From: CANN, GORDON M.; BAZARGAN, LEILA; ARAVANIS, ALEX
To: ILLUMINA, INC.
Reel/Frame 056069/0440 →
Continuity (4)
Continuation 17011923 · Sep 3, 2020
Division 15565637
Provisional Application 62145874 · Apr 10, 2015
Related Publication 20210292822A1 · Sep 23, 2021
Cited By (49)
US 12,195,790 US 12,203,134 US 12,209,280 US 12,223,751 US 12,228,544 US 12,234,505 US 12,241,060 US 12,241,890 US 12,249,085 US 12,265,079 US 12,270,077 US 12,275,988 US 12,281,357 US 12,286,673 US 12,287,264 US 12,297,486 US 12,297,487 US 12,297,488 US 12,319,955 US 12,344,892 US 12,365,935 US 12,365,942 US 12,371,688 US 12,378,607 US 12,385,083 US 12,391,979 US 12,391,980 US 12,399,123 US 12,404,544 US 12,405,264 US 12,416,603 US 12,435,363 US 12,442,045 US 12,497,654 US 12,508,590 US 12,529,094 US 12,545,949 US 12,553,805 US 12,553,898 US 12,566,113 US 12,566,114 US 12,571,029 US 12,624,392 US 12,624,475 US 12,637,706 US 12,655,473 US 12,655,478 US 12,668,835 US 12,692,492